Peptide Therapeutics Contract API Manufacturing Market Projected to Grow Significantly
2025-06-10
Market projected to grow through 2035, driven by chronic disease prevalence, synthesis technology advances, and increased outsourcing to CMOs.
The global peptide therapeutics contract API manufacturing market is anticipated to demonstrate significant growth through 2035, driven by the rising incidence of chronic and life-threatening diseases such as cancer and metabolic disorders.
Pharmaceutical companies are increasingly outsourcing API production, driven by growing regulatory complexity and cost pressures, particularly for specialized and customized peptide drugs. Innovations in peptide synthesis technology, including solid-phase peptide synthesis (SPPS), microwave-aided synthesis, and automated equipment, have transformed production, enabling higher purity, reduced production times, and lower costs.
The pre-clinical segment dominated the market in 2025, as CMOs provide specialized services including complex peptide synthesis, analytical method development, and regulatory consultancy crucial for screening new drug candidates.
Read Full Source Article